Chaim Hurvitz - 30 Aug 2023 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Chaim Hurvitz
Issuer symbol
NRXP
Transactions as of
30 Aug 2023
Net transactions value
+$20,125
Form type
4
Filing time
11 Sep 2023, 10:15:13 UTC
Previous filing
27 Sep 2023
Next filing
25 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock, par value $0.001 per share Purchase $20,125 +70,000 +14% $0.2875 570,000 30 Aug 2023 Direct F1
holding NRXP Common Stock, par value $0.001 per share 1,436,350 30 Aug 2023 By Shirat HaChaim Ltd. F2
holding NRXP Common Stock, par value $0.001 per share 208,443 30 Aug 2023 By CH Health-Private Venture Capital Ltd. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.
F2 Chaim Hurwitz is the owner of Shirat HaChaim Ltd.
F3 Chaim Hurwitz is the owner of CH Health-Private Venture Capital Ltd.